Kyung‐Don Kang

1.3k total citations
30 papers, 562 citations indexed

About

Kyung‐Don Kang is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Kyung‐Don Kang has authored 30 papers receiving a total of 562 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 7 papers in Oncology and 7 papers in Genetics. Recurrent topics in Kyung‐Don Kang's work include Virus-based gene therapy research (6 papers), CAR-T cell therapy research (5 papers) and Viral Infectious Diseases and Gene Expression in Insects (4 papers). Kyung‐Don Kang is often cited by papers focused on Virus-based gene therapy research (6 papers), CAR-T cell therapy research (5 papers) and Viral Infectious Diseases and Gene Expression in Insects (4 papers). Kyung‐Don Kang collaborates with scholars based in United States, South Korea and United Kingdom. Kyung‐Don Kang's co-authors include Bruce D. Hammock, Su‐Il Seong, Shizuo G. Kamita, Young Shik Park, Qihong Huang, Bora İnceoğlu, Andrew Hinton, Tonya F. Severson, Gregory K. Friedman and Joshua D. Bernstock and has published in prestigious journals such as Journal of Biological Chemistry, Analytical Biochemistry and Oncogene.

In The Last Decade

Kyung‐Don Kang

29 papers receiving 542 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kyung‐Don Kang United States 13 297 105 94 82 75 30 562
Márcio F.M. Alves Brazil 15 205 0.7× 29 0.3× 63 0.7× 74 0.9× 46 0.6× 20 557
Jiayong Zhu China 15 400 1.3× 64 0.6× 34 0.4× 42 0.5× 47 0.6× 50 670
Jürgen Krauß Germany 16 312 1.1× 51 0.5× 30 0.3× 53 0.6× 144 1.9× 63 769
Phuong Tran Australia 14 254 0.9× 30 0.3× 35 0.4× 118 1.4× 68 0.9× 34 562
Gang Lǚ United States 10 178 0.6× 86 0.8× 86 0.9× 47 0.6× 21 0.3× 15 552
Durvanei Augusto Maria Brazil 13 245 0.8× 40 0.4× 50 0.5× 53 0.6× 31 0.4× 29 510
Gilles A. Robichaud Canada 18 527 1.8× 30 0.3× 31 0.3× 106 1.3× 73 1.0× 53 927
Zhikun Liang China 13 246 0.8× 236 2.2× 40 0.4× 46 0.6× 116 1.5× 40 563
Habib Karoui Tunisia 21 568 1.9× 85 0.8× 475 5.1× 53 0.6× 112 1.5× 38 961
R. J. L. Munks United Kingdom 10 516 1.7× 130 1.2× 80 0.9× 72 0.9× 67 0.9× 17 933

Countries citing papers authored by Kyung‐Don Kang

Since Specialization
Citations

This map shows the geographic impact of Kyung‐Don Kang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kyung‐Don Kang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kyung‐Don Kang more than expected).

Fields of papers citing papers by Kyung‐Don Kang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kyung‐Don Kang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kyung‐Don Kang. The network helps show where Kyung‐Don Kang may publish in the future.

Co-authorship network of co-authors of Kyung‐Don Kang

This figure shows the co-authorship network connecting the top 25 collaborators of Kyung‐Don Kang. A scholar is included among the top collaborators of Kyung‐Don Kang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kyung‐Don Kang. Kyung‐Don Kang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Totsch, Stacie K., Andrew S. Ishizuka, Kyung‐Don Kang, et al.. (2024). Combination Immunotherapy with Vaccine and Oncolytic HSV Virotherapy Is Time Dependent. Molecular Cancer Therapeutics. 23(9). 1273–1281. 3 indexed citations
2.
Nazam, Nazia, Jerry E. Stewart, Kyung‐Don Kang, et al.. (2024). PP2A activation overcomes leptomeningeal dissemination in group 3 medulloblastoma. Journal of Biological Chemistry. 300(11). 107892–107892. 1 indexed citations
3.
Thompson, Eric M., Kyung‐Don Kang, Hengshan Zhang, et al.. (2024). Elucidating cellular response to treatment with viral immunotherapies in pediatric high-grade glioma and medulloblastoma. Translational Oncology. 40. 101875–101875. 2 indexed citations
4.
Bernstock, Joshua D., Sarah E. Blitz, Kyung‐Don Kang, & Gregory K. Friedman. (2023). Intraventricular immunovirotherapy; a translational step forward. Oncotarget. 14(1). 40–43. 5 indexed citations
5.
Kang, Kyung‐Don, Joshua D. Bernstock, Stacie K. Totsch, et al.. (2022). Safety and Efficacy of Intraventricular Immunovirotherapy with Oncolytic HSV-1 for CNS Cancers. Clinical Cancer Research. 28(24). 5419–5430. 11 indexed citations
6.
Kang, Kyung‐Don, Stacie K. Totsch, Sam E. Gary, et al.. (2022). Clinical advances in oncolytic virotherapy for pediatric brain tumors. Pharmacology & Therapeutics. 239. 108193–108193. 40 indexed citations
7.
Bernstock, Joshua D., Kyung‐Don Kang, Neil V. Klinger, et al.. (2022). Targeting oncometabolism to maximize immunotherapy in malignant brain tumors. Oncogene. 41(19). 2663–2671. 12 indexed citations
8.
Totsch, Stacie K., Charles Schlappi, Kyung‐Don Kang, et al.. (2019). Oncolytic herpes simplex virus immunotherapy for brain tumors: current pitfalls and emerging strategies to overcome therapeutic resistance. Oncogene. 38(34). 6159–6171. 53 indexed citations
9.
Kim, In Ho, et al.. (2012). The Benefits of Using Bacillus as a Probiotic. Journal of Animal and Veterinary Advances. 11(18). 3457–3462. 5 indexed citations
10.
Lim, Kyu Hee, Young Shik Park, Kyung‐Don Kang, et al.. (2012). Assessment of antidiabetogenic potential of fermented soybean extracts in streptozotocin-induced diabetic rat. Food and Chemical Toxicology. 50(11). 3941–3948. 25 indexed citations
11.
Kim, Hyun‐Su, et al.. (2011). Isolation and Identification of a Bacillus sp. producing α-glucosidase Inhibitor 1-deoxynojirimycin.. 39(1). 49–55. 15 indexed citations
12.
Kang, Kyung‐Don, Young Shik Park, Sang Ki Rhee, et al.. (2011). Identification of the genes involved in 1-deoxynojirimycin synthesis in Bacillus subtilis MORI 3K-85. The Journal of Microbiology. 49(3). 431–440. 38 indexed citations
13.
Kang, Kyung‐Don, Shizuo G. Kamita, Koichi Suzuki, & Su‐Il Seong. (2010). Comparative Analysis of $\alpha$ -glucosidase Activity in Bombyx mori and Antheraea yamamai. International Journal of Industrial Entomology. 21(2). 163–167. 2 indexed citations
14.
Kang, Kyung‐Don, Shizuo G. Kamita, Koichi Suzuki, & Su‐Il Seong. (2010). Effect of starvation upon baculovirus replication in larval Bombyx mori and Heliothis virescens. Journal of Invertebrate Pathology. 106(2). 205–210. 8 indexed citations
15.
Kang, Kyung‐Don, Paul D. Jones, Huazhang Huang, et al.. (2005). Evaluation of α-cyano ethers as fluorescent substrates for assay of cytochrome P450 enzyme activity. Analytical Biochemistry. 344(2). 183–192. 8 indexed citations
16.
McAbee, Rory D., Kyung‐Don Kang, J. A. Christiansen, et al.. (2003). Pyrethroid tolerance in Culex pipiens pipiens var molestus from Marin County, California. Pest Management Science. 60(4). 359–368. 77 indexed citations
17.
İnceoğlu, Bora, Shizuo G. Kamita, Andrew Hinton, et al.. (2001). Recombinant baculoviruses for insect control. Pest Management Science. 57(10). 981–987. 102 indexed citations
18.
Kang, Kyung‐Don, et al.. (2000). Ecdysteroid Stimulates Virus Transmission in Larvae Infected with Bombyx mori Nucleopolyhedrovirus. BMB Reports. 33(1). 63–68. 3 indexed citations
19.
Kang, Kyung‐Don & B. J. McCoy. (1989). Protein separation by ion exchange chromatography: A model for gradient elution. Biotechnology and Bioengineering. 33(6). 786–790. 12 indexed citations
20.
Dresel, S., et al.. (1989). Gichttophus der Schädelbasis. RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren. 150(5). 613–614. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026